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Purpose. Despite the increasing popularity of marathon running, there are no data on the responses of stroke volume (SV) and
cardiacoutput(CO)toexerciseinthiscontext.Wesoughttoestablishwhethermarathonperformanceisassociatedwiththeability
to sustain high fractional use of maximal SV and CO (i.e, cardiac endurance) and/or CO, per meter (i.e., cardiac cost). Methods.
We measured the SV, heart rate (HR), CO, and running speed of 14 recreational runners in an incremental, maximal laboratory
test and then during a real marathon race (mean performance: 3hr 30min ± 45min). Results. Our data revealed that HR, SV
and CO were all in a high but submaximal steady state during the marathon (87.0 ± 1.6%, 77.2 ± 2.6%, and 68.7 ± 2.8% of
maximal values, respectively). Marathon performance was inversely correlated with an upward drift in the CO/speed ratio (mL of
CO×m−1)( r =− 0.65, P<0.01) and positively correlated with the runner’s ability to complete the race at a high percentage of the
speed at maximal SV (r = 0.83, P<0.0002). Conclusion. Our results showed that marathon performance is inversely correlated
with cardiac cost and positively correlated with cardiac endurance. The CO response could be a benchmark for race performance
in recreational marathon runners.
1.Introduction
Endurance running capacity may have initially arisen in the
genus Homo [1, 2]. Over the course of evolution, human
physiology has been optimized for covering large distances
every day, in order to ﬁnd enough food to sustain the brain’s
metabolism. Indeed, the increasing popularity of marathon
running in modern humans of all ages and abilities can be
viewed as a legacy of our species’ evolutionary capacity to
run long distances (>5km) using aerobic metabolism [2].
Indeed, the number of starters in the London Marathon
has risen from 7,000 to 35,000 over the last 30 years and
participation in road racing in general has increased by
more than 50% over the last decade [3–5]. The increasing
popularity of road running is typiﬁed by the emergence of
recreational marathon runners who complete the 42.195km
e v e n ti nat i m eo fb e t w e e n2h r4 0m i na n d4h r4 0m i n .T h e
marathon’s potentially negative impact on cardiac status and
the occurrence of sudden cardiac deaths during this type of
e v e n th a v ep r o m p t e dm u c hd e b a t e[ 3].
Along with ˙ VO2max and energy cost, endurance (i.e.,
the ability to sustain a high fraction of ˙ VO2max)i so n eo f
the three benchmarks for overall performance in marathon
running [6]. Indeed, high-level runners display high frac-
tional use of their maximal oxygen uptake ( ˙ VO2max), with
peak recorded values of 88% [6, 7]. In two recreational
runners, Maron et al. used direct measurements to show
that the fractional use of ˙ VO2max ranged between 68% and
100% at various points in a free-pace marathon race [8].
These data suggest that cardiac strain is quite high [6, 9–11].
Hence, the question of physiological strain also arises when
considering the emerging class of middle-aged, recreational
marathon runners; the evaluation of cardiac strain and
cardiac responses during a marathon is, therefore, a topic of
legitimate interest. Other studies have reported a progressive
increaseinfractionaluseofthemaximumheartrate(HRmax)2 The Scientiﬁc World Journal
overthecourseoftherace(fromaround80%ofHRmax atthe
start to around 90% at the ﬁnish) [12–14]. This HR increase
was associated with a continuous speed decrease, starting
halfway through the race (i.e., at 21km). The upward drift
in HR is one component of so-called “cardiovascular drift,”
which is also characterized by a decrease in stroke volume
(SV) and in arterial and pulmonary pressures. Depending on
theexerciseintensity,cardiacoutput(CO)mayormaynotbe
maintained over time according to the [15]. However, to the
best of our knowledge, no data on the CO response during a
marathon race are available.
An increasing number of recreational marathon runners
are now using data from HR and speed monitors in an
attempttopacetheireﬀort.Therearecurrentlynoguidelines
on how to use these variables to optimize performance
[16]. Furthermore, there is still debate as to limiting factors
in marathon racing in general and cardiac limitation in
particular [17–19]. Hence, we continuously measured SV,
HR, CO, and speed over the course of a marathon race
andsoughttoestablishwhethermarathonperformance(and
notably the speed decrease typically seen over the second
half of the race) is associated with the ability to sustain
high fractional use of the maximal SV and CO (i.e., cardiac
endurance) and/or with the CO per meter (i.e., cardiac cost).
2. Methods
2.1. Subjects. We investigated performance in 14 middle-
aged,male,recreationalmarathonrunners(allofwhomwere
national-level short-distance triathletes or international-
level cyclists). The subjects were free of known cardiac and
pulmonary diseases. The study population’s physical charac-
teristics(mean±SDage: 37±6 years;weight:71±8kg;height
178 ± 6cm) are summarized in Table 1.E a c hs u b j e c tw a s
familiarized with the experimental procedures prior to the
study measurements. Before participation, subjects received
a verbal explanation of the nature of the study (including the
risks associated with performing a maximal physical eﬀort)
and voluntarily gave their written, informed consent. The
present study complied with the ethical standards set by
the Declaration of Helsinki and all study procedures were
approved by the local investigational review board.
2.1.1. Experimental Design. Two weeks before participation
in the Paris marathon, the subjects performed a laboratory-
based incremental test on a treadmill. This test was per-
formed until exhaustion and enabled us to record the
maximal values of a number of physiological parameters.
The laboratory-based protocol also enabled the subjects to
familiarize themselves with the material to be worn on race
day.
2.1.2. Laboratory Tests
Protocol. After familiarization with the laboratory and the
test procedures, the subjects each performed a conven-
tional, incremental running test on a treadmill (h/p/cosmos,
Nussdorf-Traunstein, Germany) until volitional exhaustion.
The running speed was set to 8km/h and then increased by
1km/h every 3min until exhaustion. The subjects were given
verbal encouragement during the test. We determined the
maximal oxygen uptake (v ˙ VO2max), maximal HR (HRmax),
maximal SV (SVmax), speed at SVmax (vSVmax) [17, 20], and
speed at the lactate threshold (vLT).
2.1.3. Data Collection Procedures
Measurement of Gas Exchanges during the Test. Oxygen
uptake was measured breath-by-breath using a Quark b2
(Cosmed, Rome, Italy). Expired gas concentrations were
averaged every 5s. Before each test, the Quark b2 was
calibrated according to the manufacturer’s instructions.
The turbine ﬂow-meter was calibrated using a 3L syringe
(Quinton Instruments, Seattle, WA) [21].
Blood Lactate Measurements. Capillary blood was sampled
fromaﬁngertipandassayedforlactate(LactateProLT,Arkay
Inc., Kyoto, Japan) [22]). For the test, samples were taken
at rest, at the end of each stage, at the end of the test, and
after two and four minutes of posttest recovery. The ˙ VO2 at
the LT was deﬁned as the starting point of a rapid lactate
accumulationof ∼4mMandwasexpressedasapercentageof
˙ VO2max[23]. For the marathon, blood lactate was measured
at the start of the race and two minutes after the ﬁnish.
Cardiovascular Measurements. An impedance cardiogra-
phy device (PhysioFlowType PF05L1, Manatec, Macheren,
France) was used to determine HR, SV, and CO during the
test and during the marathon. This device is exactly the
same as the manufacturer’s PhysioFlow Lab1 system but had
been miniaturized for the purposes of the present study. The
theoretical basis for this technique and its application to and
validityinexercisetestinghavebeendescribedbyothers[24–
28] and in our laboratory [29].
To calculate SV, the PhysioFlow measures changes
in transthoracic impedance (dZ) during cardiac ejection.
The PhysioFlow emits high-frequency (75kHz) and low-
amperage (3.8mA peak-to-peak) alternating electrical cur-
rentviaskinelectrodes[19].Twopairsofelectrodes(apairof
transmittersandapairofreceivers)areappliedoneabovethe
others(soastonotoverlap)atthesupraclavicularfossaatthe
left base of the neck and at the midpoint of the thoracic spine
region. An additional pair of electrodes is used to monitor
a single electrocardiogram (ECG) lead placed in the V1/V6
position. After entry of patient data (including the resting
systolic and diastolic blood pressure values), the resting
stroke volume index (SVical,m L ·m−2) is initially evaluated
during an auto-calibration procedure for 30 consecutive
heartbeats recorded in a seated, upright position. The auto-
calibration stores the largest impedance variation during
systole (Zpeak−Zmin) and the largest rate of variation of the
impedance signal (the contractility index, dZ/dtpeak). The
magnitude of the SVi depends on the thoracic ﬂow inversion
time (TFIT, m·s−1), measured from the ﬁrst derivative of the
impedance signal. In fact, TFIT is the time interval between
the ﬁrst zero value after the beginning of the cardiac cycleThe Scientiﬁc World Journal 3
Table 1: The subjects’ characteristics and values during the incremental test.
Runner
Characteristics Values during the incremental test
Age BMI SVmax HRmax COmax vLT vSVmax vpeak
1 27 18.3 147 189 25.6 12 11 15
2 30 24.0 180 191 26.1 10 11 14
3 39 24.2 182 200 26.7 11 12 15
4 36 23.3 174 192 28.0 14 15 17
5 39 21.6 197 189 33.7 15 14 18
6 36 22.5 179 199 29.9 12 11 15
7 34 20.8 163 187 25.5 15 13 17
8 37 23.2 198 190 35.4 13 13 17
9 45 22.1 185 179 23.3 12 13 16
10 47 21.0 166 190 27.4 15 13 19
11 33 23.4 175 181 29.5 12 15 16
12 36 23.6 180 187 22.6 12 12 16
13 35 24.6 180 186 27.4 11 12 16
14 46 20.8 163 180 24.3 12 12 14
Mean 37 22.4 176 189 27.5 13 13 16
SD 6 1.7 14 6 3.7 2 1 1
Age(yrs);BMI:bodymassindex;SV max:maximalstrokevolume(mL);HRmax:maximalheartrate(beats·min−1);COmax:maximalcardiacoutput(L·min−1);
vLT: speed at the lactate threshold (km·h−1); vSVmax: speed at the maximal stroke volume (km·h−1); vpeak: maximal speed (km·h−1).
(the start of the QRS complex on the ECG) and the ﬁrst
trough after the peak ejection velocity (dZ/dtpeak). During
data acquisition, variations in these parameters are analyzed
and compared with those obtained during calibration. The
parameter SVical is calculated according to the following
formula:
SVical = k ×
 (dZ/dt max)
(Z max−Z min)

×W(TFITcal),( 1 )
where k is an empirically adjusted constant and W is a pro-
prietary correction algorithm. Each displayed SV represents
the mean value over a 15s, artifact-free period [19, 30]. The
devicecalculatesCO(inL·min−1)accordingtothefollowing
formula:
CO = HR ×SVi ×BSA, (2)
where HR is based on the R-R interval in the ﬁrst derivative
of the ECG signal (dECQ/t, which provides a more stable
signal than the ECG itself), SVi is determined as above, and
the body surface area (BSA) is the calculated according to
Haycock’s equation:
BSA = 0.024265 ×BM0.5378 ×H0.3964, (3)
where BM is the body mass in kg and H is the height in
cm. According to the manufacturer, the PhysioFlow is novel
becauseitcalculatesSVindependentlyofbaselineimpedance
(Z0). The latter causes many problems in conventional
approaches to measuring bioimpedance because its value
is greatly aﬀected by hydration status, the inter-electrode
distance, and the resistivity of the blood. To avoid this
problematic variable, PhysioFlow does not measure Z0
during or after calibration and relies only on dZ. This is
important in the current investigation, since where exercise
might be expected to change the pulmonary capillary blood
volume. However, the changes in baseline thoracic Z0 caused
by ﬂuid expansion in the lungs should not disturb the
measurement (unless they have a true hemodynamic impact
which modiﬁes the pulsatile waveform morphology). The
PhysioFlow has been previously validated against the direct
Fick method. Mean diﬀerences between CO values obtained
using the direct Fick method and the PhysioFlow device are
not signiﬁcant during rest (0.04L·min−1)[ 19], submaxi-
m a le x e r c i s e( 0 . 2 9 L ·min−1)[ 19], or maximal incremental
exercise (0.58L·min−1)[ 19]. The direct Fick method is also
highlycorrelatedwiththePhysioFlowresultsduringrest(r =
0.89,P<0.001,n = 40)[19],submaximalexercise(r = 0.85,
P<0.001, n = 40) [30], and maximal exercise (r = 0.94,
P<0.01, n = 50) [30]. Strong correlations between the
direct Fick method and impedance cardiography have also
beenreportedforSV(r = 0.84,P<0.001)andCO(r = 0.98,
P<0.001) during maximal cycling exercise in young, ﬁt men
[31].
The SV and HR were measured continuously during
each test, with beat-to-beat smoothing via 5saveraging
algorithm. Before each test, the PhysioFlow was calibrated
according to the manufacturer’sinstructions. Cardiac output
was subsequently calculated using standard equations.
2.1.4. Cardiovascular Data Analysis. A ˙ VO2max plateau was
identiﬁed if the ˙ VO2 value (in mL·kg−1·min−1)f o rag i v e n
power level was less than 1.75 times that measured for the
previous power level. If no ˙ VO2max plateau was observed,
the attainment of ˙ VO2max was conﬁrmed by the following4 The Scientiﬁc World Journal
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Figure 1: running speed (as a percentage of speed at ˙ VO2max)
decreases during the marathon.
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Figure 2: Speed (km·h−1, grey line) and CO (L·min−1, black line)
during the marathon.
secondary criteria: (a) a respiratory exchange ratio greater
t h a n1 . 1 0 ,( b )a nH R> 95% of the theoretical age-predicted
maximum, (c) a rating of perceived exertion > 16, and
(d) a blood lactate concentration above 8mM.v ˙ VO2max was
deﬁned as the lowest velocity that elicited ˙ VO2max [20]. If a
subject achieved ˙ VO2maxduring the last stage but was unable
to complete the full 3 minutes, v ˙ VO2maxwas calculated as
v ˙ VO2max = vF+

t
180

×1

,( 4 )
where ﬁrst the speed at the last complete stage (m·s−1), t, is
the duration over which the last workload was maintained
(s) and 1 is the speed increment (km·h−1) between the last
two stages.
Anthropometry. Height and weight were measured before
and after each test. Five skin-fold measurements were made
(triceps, biceps, supra-iliac, subscapular, and mid-thigh) and
the percentage body fat was estimated according to the
Durnin-Womersley method [32].
2.1.5. Marathon Data Measurement and Analysis. Speed (V)
was measured using an accelerometer (the RS800 CX from
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Figure 3: Heart rate (beats·m−1, black line) and stroke volume
(mL, grey line) during the marathon.
Polar Electro Oy, Oulu, Finland) [33]. Heart rate, SV, and
COwereindexedaccordingtorunningspeed(HRS,SVS,and
COS, respectively, with the following units: beats per meter
for HRS, blood volume per beat per meter run for SVS, and
blood volume per meter run for COS). The COS parameter
was considered as an index of cardiac cost by analogy with
oxygen cost (i.e., the oxygen uptake per meter run).
2.1.6. Statistical Analysis. Descriptive statistics are quoted as
the mean and standard deviation (SD). The normality of the
data distribution was checked with a Fisher-Snedecor test.
An analysis of variance (ANOVA) for repeated measures and
aS c h e ﬀe posthoc test were applied to the V, HR, SV, CO,
HRS, SVS, and COS data for every 10% of the race distance
(i.e., every 4km). Furthermore, a Student’s t-test for paired
data was used to compare the cardiac responses measured
during the marathon and during the incremental test. For
each individual, the slope of the plots of HRS, SVS, and COS
against performance (i.e., the average marathon speed) were
assessed using least-squares linear regression. The threshold
for statistical signiﬁcance was set to P<0.05.
3. Results
3.1. Fractional Use of SV, HR, CO, and Speed during the
Marathon Race. Before considering the fractional use of
maximal cardiac parameters, it must be borne in mind
that the average marathon speed (vMar) in this group
of recreational marathon runners group was submaximal
(73.8 ± 8.8% of v ˙ VO2max, on average) (Figure 1). This
value was signiﬁcantly lower than vSVmax (80.5 ± 6.1%
v ˙ VO2max)a n dv L T( 7 9 .7 ± 4.8% ˙ VO2max) measured during
theincrementaltest(Tables1and2).FractionaluseofSVmax,
HRmax, and COmax during the race is summarized in Table 1.
On average, the marathon race elicited 68 ± 2% of SVmax,
87 ± 2% of HRmax,a n d7 7± 3% of COmax measured in the
incremental test.
The cardiac variables, CO, SV, and HR, did not diﬀer
signiﬁcantly when comparing the ﬁrst 4km and last 4km
of the race (P = 0.2f o rC Oa n dS V ;P = 0.5 for HR; t-
test for paired data) (Figures 2 and 3). However, signiﬁcant
variations in HR over the course of the marathon wereThe Scientiﬁc World Journal 5
Table 2: Performance during the marathon race.
Runner Tmar vMar vMar%vSVmax vMar%v ˙ VO2max
1 3.51 11.0 100.0 77.3
2 4.58 08.5 77.3 60.7
3 4.08 10.2 85.0 72.9
4 3.04 13.8 92.0 81.2
5 2.52 14.7 105.0 81.7
6 3.51 11.0 100.0 73.3
7 2.58 14.2 109.2 83.5
8 3.05 13.7 105.4 85.6
9 3.39 11.6 89.2 72.5
10 2.57 14.3 110.0 79.4
11 3.45 11.2 74.4 70.0
12 5.10 08.0 66.7 53.3
13 4.02 10.5 87.5 70.0
14 3.54 10.8 90.0 77.1
Mean 3.50 11.7 92.3 73.9
SD 0.76 2.1 12.9 8.8
Tmar: marathon time (hours); vMar: mean speed for the marathon
(km·h−1), vMar%vSVmax: mean marathon speed as a percentage of
the speed at maximal stroke volume during the incremental test;
vMar%v ˙ VO2max: mean marathon speed as a percentage of the speed at
maximal oxygen uptake during the incremental test.
revealed by an ANOVA with repeated measures. Indeed,
the HR increased until km 12, stabilized until km 28 and
then decreased to the ﬁnish (F = 3.0, P = 0.003)
(Figure 3). However, this stabilization in cardiac parameters
must be viewed in light of the mean 18 ± 9% decrease in
running speed between km 12 and the ﬁnish (P<0.0001).
Accordingly, the values per meter run were signiﬁcantly
greater for km 36–40 than for km 8–12 (Table 3), with
increases of 21 ± 16% for HRS (Figure 4(a)), 25 ± 17% for
SVS (Figure 4(b)), and 26 ±22% for COS (Figure 4(c)). The
COS increase was caused by upward drifts in HRS (r = 0.69,
P = 0.005) and SVS (r = 0.85, P<0.0001) but not by
the speed decrease (r =− 0.23, P = 0.42). In contrast,
the increase in HRS was highly correlated with the speed
decrease between km 8–12 and km 36–40.
3.2. Marathon Performance Correlates Negatively with the
Upward Drift in the COS (Cardiac Cost) but Positively with
the Ability to Sustain High Fractional Use of the Maximal SV
and CO (Cardiac Endurance). In contrast to what is often
believed, the speed decrease was not correlated with overall
performance; the fastest runners overall were not those who
had the smallest relative speed decrease (as a percentage of
the speed at km 12) (r = 0.39, P = 0.16). However, the
present study conﬁrmed that as typically reported, marathon
performance was strongly correlated with ˙ VO2max (r = 0.83,
P<0.0002, Figure 5) and the fractional use of ˙ VO2max
at vLT (r = 0.59, P = 0.03) but not with the fractional
use of ˙ VO2max at the maximal stroke volume reached in the
incremental test (84.9 ± 10.5%) (P = 0.65). The cardiac
response during the incremental test was not correlated with
marathon performance; the cardiac response during the race
itself was the marathon performance factor. Indeed, the
fractional use of SVmax and of vSVmax during the marathon
was moderately and strongly correlated with performance
(r = 0.67, P = 0.03 and r = 0.83, P = 0.0002), respectively
(Figure 6). This ﬁnding suggests that the best recreational
marathon runners are those who (i) can sustain a high
fraction of their vSVmax and (ii) have the lowest absolute
diﬀerence between vSVmax and vMar (r =− 0.78, P =
0.0009) (Figure 7).
The relationship between our cardiac marathon perfor-
mance indicators and conventional indicators is shown by
the observation that the sustained fractional use of v ˙ VO2max
during the marathon was strongly and positively correlated
with the fractional use of vSVmax (r = 0.86, P<0.0001) and
inversely correlated with the upward drift in the CO/speed
ratio (mL of CO ×m−1)( r =− 0.65, P<0.01) (Figure 8).
4. Discussion
The present study is the ﬁrst to evidence CO strain during
a real race. Our results suggest that endurance performance
in marathon running can most usefully be measured during
the race itself by applying novel techniques for cardiac data
collection. By applying an in-the-ﬁeld approach, we found
that marathon performance by middle-aged, recreational
runners was associated with the ability to sustain high
fractional use of the maximal SV and CO (i.e., cardiac
endurance) and/or the CO per meter (i.e., cardiac cost).
Crandall and Gonzal´ ez-Alonso [26] have reported that
a drop in SV may be a major limiting factor in exhaustive
exercise [34]. However, we showed here that SV did not
decreaseovertime; this agreeswithpreviousreports ofanSV
steady state during large reductions in brain perfusion in the
heat-stressed human and during intense, endurance exercise
[26]. Indeed, SV remained at submaximal steady state (77 ±
3%), as did CO (69 ± 3%). Furthermore, an increase in HR
in a neutral environment has been shown to be responsible
for the SV decline in steady exercise performed for 1 hour
at 57% of ˙ VO2max [35]. Therefore, in the present study, it was
importanttocheckwhetherSVdeclinedandHRincreasedin
a longer, more intense bout of exercise like the marathon. In
the marathon studied here, we did not observe the cardiac
drift that may be responsible for an increase in cardiac
oxygen uptake (as estimated by the double product) during
constant-load exercise [26]. Indeed, the runners’ mean HR
remainedatahigh,steadystatethroughouttherace(87±2%
of HRmax).
To the best of our knowledge, the hypothesis where by
cardiac limitation is a marathon performance factor has
not previously been evaluated directly. However, our direct,
intrarace measurements showed that cardiac strain (CO, SV,
and HR) remained in a submaximal, steady state; this was
probably due to the decrease in running speed after km
12. However, this speed drop was not correlated with ﬁnal
performance; the best runners were not those who reported
the lowest relative speed decrease between the ﬁrst four km
of the race and last four km.6 The Scientiﬁc World Journal
Table 3: SV, HR, CO and speed (v%vMar) every 4km of the marathon race, all expressed as a percentage of the maximal values in the
incremental test.
Race km SV% SVmax HR% HRmax CO% COmax v%v ˙ VO2max
47 2 .2 ±11.38 4 .6 ±7.47 6 .6 ±23.08 1 .1 ±9.4
87 3 .0 ±11.88 7 .5 ±4.28 0 .6 ±23.48 1 .3 ±7.5
12 76.0 ±9.68 9 .1 ±4.08 5 .0 ±23.18 1 .5 ±6.4
16 78.4 ±11.98 8 .8 ±3.88 5 .0 ±23.17 8 .6 ±8.1
20 79.4 ±12.78 8 .4 ±3.18 3 .5 ±17.27 9 .0 ±8.4
24 79.4 ±11.08 8 .1 ±4.98 6 .1 ±16.87 6 .6 ±9.0
28 78.0 ±8.88 8 .3 ±4.98 5 .9 ±18.27 4 .4 ±5.2
32 77.6 ±10.38 5 .0 ±7.38 2 .6 ±18.47 1 .8 ±8.9
36 78.8 ±12.48 5 .4 ±7.58 2 .9 ±15.86 6 .6 ±6.2
40 78.7 ±9.88 6 .3 ±8.58 4 .7 ±18.46 7 .0 ±7.5
Mean 77.2 ±11.08 7 .2 ±5.68 3 .3 ±19.77 5 .7 ±7.7
Values are presented as the mean ± SD.
SV: stroke volume; HR: heart rate; CO: cardiac output; v%v ˙ VO2max: the racing speed as a percentage of the speed at ˙ VO2maxrecorded in the incremental test.
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Figure 4: Increases in the heart rate per meter run (HRS, panel (a)), stroke volume per meter run (SVS, panel (b)),and blood ﬂow per meter
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As a result of the speed decrease and a steady state for
the cardiac variables, the values per meter run (COS, SVS,
and HRS) increased after km 12. Interestingly, the amplitude
of the increase in COS (cardiac cost) between km 12 and the
endracewasstronglycorrelatedwithmarathonperformance
(i.e., ﬁnishing time or average speed) and could be an
important performance predictor. This cardiac cost increase
couldberelatedtotheenergycost,whichhasbeenshown(in
treadmill measurements) to be greater just after a marathon
[6].
Lastly, our results prompted us to hypothesize that
cardiac strain is both a pace maker and a consequence of
the decrease in racing speed after km 12 (i.e., after about
90 minutes of running, on average). The speed decrease
is thought to be due to glycogen and metabolic lim-
itations, as reported by Rapoport [36]. Indeed, the latter
author demonstrated that glycogen storage capacity was
only a performance-limiting factor in runners with low or
moderate aerobic capacities ( ˙ VO2max < 60mL·kg−1·min−1)
or with relatively small leg muscles. The performance levels
of the recreational marathon runners studied here are in
accordance with Rapoport’s predictions [36] on the basis of
the percentage HRmax, the ˙ VO2max, and the LT. Therefore,
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Figure 7: The relationship between mean speed in the marathon
(km·h−1) and the diﬀerence between vSVmax and vMar (km·h−1).
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Figure 8: The relationship between mean speed in the marathon
(km·h−1) and the drift in blood ﬂow per meter run (COS) during
the race (mL·m−1).
the limitation on marathon performance must also include
running economy. The latter depends on the cardiac cost,
which in turn depends on the HR and thus the number of
heart beats per km. Hence, these two hypotheses are not
mutually exclusive, since the fractional use of SV, HR, and
CO are not performance factors in marathon racing.
5. Conclusion
Our results showed that marathon performance is inversely
correlated with an upward drift in the CO per meter
ran (i.e., cardiac cost) and positively correlated with the
ability to sustain high fractional use of the maximal
SV and CO (i.e., cardiac endurance). Therefore, the CO
response during the race could be a performance benchmark
in recreational marathon runners. The present study of
intersubject diﬀerences in performance factors is not a
suﬃciently methodological approach for explaining intra-
subjectmarathonperformancelimitations.Thistypeofwork
would require further intramarathon measurements (such
as oxygen uptake and integrated electromyography) that are
now becoming accessible with portable systems.8 The Scientiﬁc World Journal
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